ANNA LEDFORD: Open Payments
NPI 1154671063 · VALDOSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$81,428 in 280 payments from 7 companies in 2025. Trend: 2023 $68 · 2024 $25,892 · 2025 $81,428
Speaker / faculty: $62,025Travel & lodging: $16,924Food & beverage: $2,479
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 273 | $81,049 |
| Dexcom, Inc. | 1 | $160 |
| Amgen Inc. | 2 | $108 |
| Gilead Sciences, Inc. | 1 | $56 |
| ABBVIE INC. | 1 | $20 |
| Pulmonx Corporation | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: ZEPBOUND, DEXCOM G7 GSS (161), REPATHA, Biktarvy, MOUNJARO, UBRELVY, CHARTIS CATHETER, CAPLYTA.
Industry payments across GA — which companies pay providers there.
